EDGAR Filing Documents for 0001193125-12-043909

Form 8-K - Current report:

SEC Accession No. 0001193125-12-043909

Filing Date

2012-02-07

Accepted

2012-02-07 16:58:56

Documents

Period of Report

2012-02-01

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d295862d8k.htm	8-K	31956
2	AMENDMENT NO. 1 TO THE AGREEMENT AND PLAN OF MERGER, DATED DECEMBER 28, 2011	d295862dex21.htm	EX-2.1	39290
3	STOCK PURCHASE AGREEMENT	d295862dex101.htm	EX-10.1	155003
4	CREDIT AGREEMENT	d295862dex102.htm	EX-10.2	1357780
5	PRESS RELEASE ISSUED BY ALEXION PHARMACEUTICALS, INC. ON FEBRUARY 7, 2012	d295862dex991.htm	EX-99.1	3030
6	GRAPHIC	g295862g48m94.jpg	GRAPHIC	5353
	Complete submission text file	0001193125-12-043909.txt		1595968

Mailing Address 352 KNOTTER DRIVE CHESHIRE CT 06511

Business Address 352 KNOTTER DRIVE CHESHIRE CT 06511 2037761790

ALEXION PHARMACEUTICALS INC (Filer) CIK: 0000899866 (see all company filings)